T-Cell-Rich B-Cell Non-Hodgkin's Lymphoma Mimicking Hodgkin's Disease

References

• Ramsay A D, Smith W J, Isaacson P G. T‐cell‐rich B‐cell lymphoma. Am J Surg Pathol 1992; 12: 433–43
   Web of Science ®Google Scholar
• Mirchandani I, Palutke M, Tabacza P, et al. B‐cell lymphomas morphologically resembling T‐cell lymphomas. Cancer 1986; 56: 1578–83
   Web of Science ®Google Scholar
• Jaffe E S. Pseudoperipheral T cell lymphomas. Surgical pathology of the lymph nodes and related organs, E S Jaffe. WB Saunders, Philadelphia 1985; 230–31
   Google Scholar
• Radford J A, Whelan J S, Rohatiner A Z, et al. Weekly VAPEC‐B chemotherapy for high grade non‐Hodgkin's lymphoma: results of treatment in 184 patients. Ann Oncol 1994; 5(2)147–151
   PubMed Web of Science ®Google Scholar
• Magrath J, Adde M, Horak I, et al. Adults and children with small non‐cleaved‐cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996; 14(3)925–934
   PubMed Web of Science ®Google Scholar
• Hsu S M, Raine L, Fanger H. Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) prcedures. J Histochem Cytochem 1981; 29: 577–580
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch E F, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbour Laboratory Press. 1989
   Google Scholar
• Trainor K J, Brisco M J, Wan J H, et al. Gene rearrangement in Band T‐lymphoproliferative disease detected by polymerase chain reaction. Blood 1991; 78: 192–196
   PubMed Web of Science ®Google Scholar
• Kneba M, Eick S, Herbst H, et al. Frequency and structure of t(14;18) major breakpoint regions in Non‐Hodgkin's lymphoma typed according to the Kiel classification: analysis by DNA sequencing. Cancer Res 1991; 51: 3243–3250
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Pugh W C, Cabanillas F. T‐cell‐rich B‐cell lymphoma. Blood 1993; 82: 1586–89
   PubMed Web of Science ®Google Scholar
• Macon W R, Williams M E, Greer J P, et al. T‐cell‐rich B‐cell lymphomas. A clinicopathological study of 19 cases. Am J Surg Pathol 1992; 16: 351–63
   PubMed Web of Science ®Google Scholar
• Ng C S, Chan J K, Hui P K, et al. Large B‐cell lymphomas with a high content of reactive T cells. Hum Pathol 1989; 20: 1145–54
   PubMed Web of Science ®Google Scholar
• Osborne B M, Butler J JJ, Pugh W C. The value of immunophenotyping on paraffin sections in the identification of T‐cell rich B‐cell large‐cell lymphomas. Am J Surg Pathol 1990; 14(10)933–38
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Longe D L, Cossman J, et al. Diffuse B cell lymphoma with T cell predominance in patients with follicular lymphoma or “pseudo T cell lymphoma”. Lab Invest 1984; 50: 27A–28A
   Web of Science ®Google Scholar
• Baddoura F K, Chan W C, Masih A S, et al. T‐cell rich B‐cell lymphoma: a clinicopathological study of eight cases. Am J Clin Pathol 1995; 103: 65–75
   PubMed Web of Science ®Google Scholar
• Mc Bride A, Rodriguez J, Luthra R, et al. T‐cell‐rich B large cell lymphoma simulating lymphocyte‐rich Hodgkin's disease. Am J Surg Pathol 1996; 20(2)193–201
   PubMed Web of Science ®Google Scholar
• Krishnan J, Wallberg K, Frizzera G. T‐cell‐rich large B‐cell lymphoma. Am J Surg Pathol 1994; 18(5)455–65
   PubMed Web of Science ®Google Scholar
• Lennert K, Feller A C. Histopathology of Non‐Hodgkin's lymphomas based on the updated Kiel classificationSecond, completely revised edition. Springer Verlag. 1991; 27, Chapter 2.3
   Google Scholar
• National Cancer Institute sponsored study of classifications of non‐Hodgkin's lymphomas:. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Lee Harris N, Jaffe E S, Stein H, et al. A revised European‐American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–92
   PubMed Web of Science ®Google Scholar
• Kamel O W, Gelb A B, Shibuya R B, Warnke R A. Leu‐7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T‐cell‐rich B‐cell lymphoma and follicular lymphoma. Am J Surg Pathol 1993; 142: 541–46
   Web of Science ®Google Scholar
• Poppema S, Kaiserling E, Lennert K. Hodgkin's disease with lymphocyte predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centers: a cytohistologic study. Histopathology 1979; 3: 295–308
   PubMed Web of Science ®Google Scholar
• Stein R S, Greer J P, Flexner J M, et al. Large‐cell lymphomas: clinical and prognostic features. J Clin Oncol 1990; 8: 1370–79
   PubMed Web of Science ®Google Scholar
• Hansmann M L, Fellbaum C, Hui P K, Zwingers T. Correlation of content of B cells and Leu7‐positive cells with subtype and stage in lymphocyte predominance type Hodgkin's disease. J Cancer Res Clin Oncol 1988; 119: 405–10
   Web of Science ®Google Scholar
• Ohshima K, Kikuchi M, Shibata T, et al. Clonal analysis of Hodgkin's disease shows absence of TCR/lg gene rearrangement, compared with T‐cell‐rich B‐cell lymphoma and incipient adult T‐cell leucemia/lymphoma. Leucemia and Lymphoma 1994; 15: 469–79
   PubMed Web of Science ®Google Scholar
• Khan G, Norton J, Slavin G. Ebstein‐Barr virus in Reed‐Stemberg‐like cells in Non‐Hodkin's lymphomas. J Pathol 1993; 169: 9–14
   PubMed Web of Science ®Google Scholar
• Greer J P, Macon W R, Lamar R E, et al. T‐cell‐rich B‐cell lymphomas: Diagnosis and Response to therapy of 44 patients. J Clin Oncol 1995; 13(7)1742–1750
   PubMed Web of Science ®Google Scholar
• Macon W R, Cousar J B, Waldron J A, et al. Interleu‐cin‐4 may contribute to the abundant T‐cell reaction and paucity of neoplastic B cells in T‐cell‐rich B‐cell lymphomas. Am J. Pathol 1992; 141(5)1031–36
   PubMed Web of Science ®Google Scholar
• Xerry L, Mathoulin M P, Birg F, et al. Heterogeneity of rearranged T‐cell receptor V‐α and V‐β transcripts in tumor‐infiltrating lymphocytes from Hodgkin's disease and Non‐Hodgkin's lymphoma. Am J Clin Pathol 1994; 101: 76–80
   PubMed Web of Science ®Google Scholar
• Dommann St, Dommann C, Zimmermann D, et al. Primary cutaneous T‐cell‐rich B‐cell lymphoma. Am J Dermatopathol 1995; 17(6)618–24
   PubMed Web of Science ®Google Scholar
• Weiss L M, Warnke R A, Sklar J, Cleary M L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987; 317: 1185–9
   PubMed Web of Science ®Google Scholar
• Khan S M, Cottrell B J, Millward‐Sadler G H, Wright D H. T‐cell rich B‐cell lymphoma presenting as liver disease. Histopathology 1993; 23: 217–24
   PubMed Web of Science ®Google Scholar
• Scarpa A, Bonetti E, Zamboni G, et al. Letters to the editor. T‐cell rich B‐cell lymphoma. Am J Surg Pathol 1989; 13: 335–7
   PubMed Web of Science ®Google Scholar
• Arai E, Sakurai M, Nakayama H, Morinaga S, Katayama I. Primary cutaneous T‐cell‐rich B‐cell lymphoma. Br J Dermatol 1993; 129: 196–200
   PubMed Web of Science ®Google Scholar
• Skinnider B, Connors J, Cascoyne R. Bone marrow involvement in T‐cell‐rich B cell lymphoma. Hematopathology 1997; 108: 570–78
   Google Scholar
• Head D R, Avakian J, Kjeldsberg C R, Cerezo L. Relapse of intermediate or high‐grade (unfavorable) non‐Hodgkin's lymphoma as a low‐grade (favorable) non Hodgkin's lymphoma. Am J Clin Pathol 1988; 89: 106–8
   PubMed Web of Science ®Google Scholar
• Chittal S M, Brousset P, Voigt J ‐J, Delsol G. Large B‐cell lymphoma rich in T‐cells and stimulating lymphocyte‐rich Hodgkin's disease. Histopathology 1991; 19: 211–220
   PubMed Web of Science ®Google Scholar
• Regula D P, Hoppe R T, Weiss L M. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 1988; 318: 214–219
   PubMed Web of Science ®Google Scholar